$PCRX Income Statement | Understand Stock

$PCRX

$36.38 -$0.04 (0.11%) Close

$PCRX Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated statements of operations

In millions of USD; shares in millions, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Revenues:
Revenues
Net product sales
Royalty revenue
Net product sales
Royalty revenue
Collaborative licensing and milestone revenue
Reportable Segment
Total revenues

Operating expenses:
Cost of goods sold
Research and development
Selling, general and administrative
Amortization of acquired intangible assets
Reportable Segment
Total amortization of acquired intangible assets
Acquisition-related charges, product discontinuation and other
Acquisition-related charges (gains), impairment and other
Goodwill impairment
Reportable Segment
Total goodwill impairment
Contingent consideration gains, acquisition-related expenses, restructuring and other
Reportable Segment
Total operating expenses

Income (loss) from operations
Other income (expense):
Interest income
Interest expense
(Loss) gain on early extinguishment of debt
Reportable Segment
Total (Loss) gain on early extinguishment of debt
Other, net
Other (expense) income, net
Reportable Segment
Total other (expense) income, net
Income (loss) before income taxes
Reportable Segment
Total income (loss) before income taxes
Income tax expense
Reportable Segment
Total income tax expense
Net income (loss)
Reportable Segment
Total net income (loss)
Net income (loss) per share:
Basic net income (loss) per common share (in dollars per share)
Diluted net income (loss) per common share (in dollars per share)
Weighted average common shares outstanding:
Basic (in shares)
Diluted (in shares)

Comments